APO Research

APO RESEARCH · REPORT

Bi Yuan Pills

Selected research

Market Outlook & Growth Opportunities

Global Bi Yuan Pills Market Outlook and Growth Opportunities 2026

Market perspective

The global Bi Yuan Pills market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bi Yuan Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bi Yuan Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bi Yuan Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bi Yuan Pills market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bi Yuan Pills market include Zhongjing Wanxi Pharmaceutical Co., Ltd., Wuhan Taifu Pharmaceutical Co., Ltd., Li Shizhen Pharmaceutical Group Co., Ltd., Hubei Minkang Pharmaceutical Co., Ltd. and Sinopharm Group Zhonglian Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bi Yuan Pills market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bi Yuan Pills and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bi Yuan Pills sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bi Yuan Pills market size, projected growth trends, production technologies, key applications, and end-use industries.

Bi Yuan Pills Segment by Company

Zhongjing Wanxi Pharmaceutical Co., Ltd.

Wuhan Taifu Pharmaceutical Co., Ltd.

Li Shizhen Pharmaceutical Group Co., Ltd.

Hubei Minkang Pharmaceutical Co., Ltd.

Sinopharm Group Zhonglian Pharmaceutical Co., Ltd.

Bi Yuan Pills Segment by Type

Boxed

Bottled

Bi Yuan Pills Segment by Application

Hospital

Clinic

Other

Bi Yuan Pills Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bi Yuan Pills status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bi Yuan Pills market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bi Yuan Pills significant trends, drivers, influence factors in global and regions.

6. To analyze Bi Yuan Pills competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bi Yuan Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bi Yuan Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bi Yuan Pills.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bi Yuan Pills market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bi Yuan Pills industry.

Chapter 3: Detailed analysis of Bi Yuan Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bi Yuan Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bi Yuan Pills in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bi Yuan Pills Industry Trends Table 2. Bi Yuan Pills Industry Drivers Table 3. Bi Yuan Pills Industry Opportunities and Challenges Table 4. Bi Yuan Pills Industry Restraints Table 5. Global Bi Yuan Pills Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bi Yuan Pills Revenue Share by Company (2021-2026) Table 7. Global Bi Yuan Pills Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Bi Yuan Pills Sales Volume Share by Company (2021-2026) Table 9. Global Bi Yuan Pills Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Bi Yuan Pills Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bi Yuan Pills Key Company Manufacturing Base & Headquarters Table 12. Global Bi Yuan Pills Company, Product Type & Application Table 13. Global Bi Yuan Pills Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bi Yuan Pills by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Boxed Table 18. Significant Companies of Bottled Table 19. Global Bi Yuan Pills Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Bi Yuan Pills Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Bi Yuan Pills Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Bi Yuan Pills Sales Volume Share by Type (2021-2026) Table 23. Global Bi Yuan Pills Sales Volume Share by Type (2027-2032) Table 24. Global Bi Yuan Pills Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bi Yuan Pills Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Bi Yuan Pills Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Bi Yuan Pills Sales Value Share by Type (2021-2026) Table 28. Global Bi Yuan Pills Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Bi Yuan Pills Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Bi Yuan Pills Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Bi Yuan Pills Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Bi Yuan Pills Sales Volume Share by Application (2021-2026) Table 36. Global Bi Yuan Pills Sales Volume Share by Application (2027-2032) Table 37. Global Bi Yuan Pills Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Bi Yuan Pills Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Bi Yuan Pills Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Bi Yuan Pills Sales Value Share by Application (2021-2026) Table 41. Global Bi Yuan Pills Sales Value Share by Application (2027-2032) Table 42. Global Bi Yuan Pills Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Bi Yuan Pills Sales by Region (2021-2026) & (K Units) Table 44. Global Bi Yuan Pills Sales Market Share by Region (2021-2026) Table 45. Global Bi Yuan Pills Sales by Region (2027-2032) & (K Units) Table 46. Global Bi Yuan Pills Sales Market Share by Region (2027-2032) Table 47. Global Bi Yuan Pills Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Bi Yuan Pills Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Bi Yuan Pills Sales Value Share by Region (2021-2026) Table 50. Global Bi Yuan Pills Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Bi Yuan Pills Sales Value Share by Region (2027-2032) Table 52. Global Bi Yuan Pills Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Bi Yuan Pills Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Bi Yuan Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Bi Yuan Pills Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Bi Yuan Pills Sales by Country (2021-2026) & (K Units) Table 57. Global Bi Yuan Pills Sales Market Share by Country (2021-2026) Table 58. Global Bi Yuan Pills Sales by Country (2027-2032) & (K Units) Table 59. Global Bi Yuan Pills Sales Market Share by Country (2027-2032) Table 60. Global Bi Yuan Pills Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Bi Yuan Pills Sales Value Market Share by Country (2021-2026) Table 62. Global Bi Yuan Pills Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Bi Yuan Pills Sales Value Market Share by Country (2027-2032) Table 64. Zhongjing Wanxi Pharmaceutical Co., Ltd. Company Information Table 65. Zhongjing Wanxi Pharmaceutical Co., Ltd. Business Overview Table 66. Zhongjing Wanxi Pharmaceutical Co., Ltd. Bi Yuan Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Zhongjing Wanxi Pharmaceutical Co., Ltd. Bi Yuan Pills Product Portfolio Table 68. Zhongjing Wanxi Pharmaceutical Co., Ltd. Recent Development Table 69. Wuhan Taifu Pharmaceutical Co., Ltd. Company Information Table 70. Wuhan Taifu Pharmaceutical Co., Ltd. Business Overview Table 71. Wuhan Taifu Pharmaceutical Co., Ltd. Bi Yuan Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Wuhan Taifu Pharmaceutical Co., Ltd. Bi Yuan Pills Product Portfolio Table 73. Wuhan Taifu Pharmaceutical Co., Ltd. Recent Development Table 74. Li Shizhen Pharmaceutical Group Co., Ltd. Company Information Table 75. Li Shizhen Pharmaceutical Group Co., Ltd. Business Overview Table 76. Li Shizhen Pharmaceutical Group Co., Ltd. Bi Yuan Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Li Shizhen Pharmaceutical Group Co., Ltd. Bi Yuan Pills Product Portfolio Table 78. Li Shizhen Pharmaceutical Group Co., Ltd. Recent Development Table 79. Hubei Minkang Pharmaceutical Co., Ltd. Company Information Table 80. Hubei Minkang Pharmaceutical Co., Ltd. Business Overview Table 81. Hubei Minkang Pharmaceutical Co., Ltd. Bi Yuan Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Hubei Minkang Pharmaceutical Co., Ltd. Bi Yuan Pills Product Portfolio Table 83. Hubei Minkang Pharmaceutical Co., Ltd. Recent Development Table 84. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Company Information Table 85. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Business Overview Table 86. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Bi Yuan Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Bi Yuan Pills Product Portfolio Table 88. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Bi Yuan Pills Distributors List Table 92. Bi Yuan Pills Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Bi Yuan Pills Product Image Figure 2. Global Bi Yuan Pills Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bi Yuan Pills Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bi Yuan Pills Sales (2021-2032) & (K Units) Figure 5. Global Bi Yuan Pills Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Bi Yuan Pills Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Boxed Image Figure 10. Bottled Image Figure 11. Global Bi Yuan Pills Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Bi Yuan Pills Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Bi Yuan Pills Sales Volume Share by Type (2021-2032) Figure 14. Global Bi Yuan Pills Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Bi Yuan Pills Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Bi Yuan Pills Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Bi Yuan Pills Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Bi Yuan Pills Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Bi Yuan Pills Sales Volume Share by Application (2021-2032) Figure 23. Global Bi Yuan Pills Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Bi Yuan Pills Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Bi Yuan Pills Sales Value Share by Application (2021-2032) Figure 26. Global Bi Yuan Pills Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Bi Yuan Pills Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Bi Yuan Pills Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Bi Yuan Pills Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Bi Yuan Pills Sales Value (2021-2032) & (US$ Million) Figure 31. North America Bi Yuan Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Bi Yuan Pills Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Bi Yuan Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Bi Yuan Pills Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Bi Yuan Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Bi Yuan Pills Sales Value (2021-2032) & (US$ Million) Figure 37. South America Bi Yuan Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Bi Yuan Pills Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Bi Yuan Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Bi Yuan Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Bi Yuan Pills Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Bi Yuan Pills Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Boxed
  • Bottled
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Zhongjing Wanxi Pharmaceutical Co., Ltd.
  • Wuhan Taifu Pharmaceutical Co., Ltd.
  • Li Shizhen Pharmaceutical Group Co., Ltd.
  • Hubei Minkang Pharmaceutical Co., Ltd.
  • Sinopharm Group Zhonglian Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bi Yuan Pills Sales Value (2021-2032)
  4. 1.2.2 Global Bi Yuan Pills Sales Volume (2021-2032)
  5. 1.2.3 Global Bi Yuan Pills Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bi Yuan Pills Market Dynamics
  1. 2.1 Bi Yuan Pills Industry Trends
  2. 2.2 Bi Yuan Pills Industry Drivers
  3. 2.3 Bi Yuan Pills Industry Opportunities and Challenges
  4. 2.4 Bi Yuan Pills Industry Restraints
3 Bi Yuan Pills Market by Company
  1. 3.1 Global Bi Yuan Pills Company Revenue Ranking in 2025
  2. 3.2 Global Bi Yuan Pills Revenue by Company (2021-2026)
  3. 3.3 Global Bi Yuan Pills Sales Volume by Company (2021-2026)
  4. 3.4 Global Bi Yuan Pills Average Price by Company (2021-2026)
  5. 3.5 Global Bi Yuan Pills Company Ranking (2024-2026)
  6. 3.6 Global Bi Yuan Pills Company Manufacturing Base and Headquarters
  7. 3.7 Global Bi Yuan Pills Company Product Type and Application
  8. 3.8 Global Bi Yuan Pills Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bi Yuan Pills Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bi Yuan Pills Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bi Yuan Pills Market by Type
  1. 4.1 Bi Yuan Pills Type Introduction
  2. 4.1.1 Boxed
  3. 4.1.2 Bottled
  4. 4.2 Global Bi Yuan Pills Sales Volume by Type
  5. 4.2.1 Global Bi Yuan Pills Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bi Yuan Pills Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Bi Yuan Pills Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Bi Yuan Pills Sales Value by Type
  9. 4.3.1 Global Bi Yuan Pills Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bi Yuan Pills Sales Value by Type (2021-2032)
  11. 4.3.3 Global Bi Yuan Pills Sales Value Share by Type (2021-2032)
5 Bi Yuan Pills Market by Application
  1. 5.1 Bi Yuan Pills Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Bi Yuan Pills Sales Volume by Application
  6. 5.2.1 Global Bi Yuan Pills Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bi Yuan Pills Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Bi Yuan Pills Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Bi Yuan Pills Sales Value by Application
  10. 5.3.1 Global Bi Yuan Pills Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bi Yuan Pills Sales Value by Application (2021-2032)
  12. 5.3.3 Global Bi Yuan Pills Sales Value Share by Application (2021-2032)
6 Bi Yuan Pills Regional Sales and Value Analysis
  1. 6.1 Global Bi Yuan Pills Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bi Yuan Pills Sales by Region (2021-2032)
  3. 6.2.1 Global Bi Yuan Pills Sales by Region: 2021-2026
  4. 6.2.2 Global Bi Yuan Pills Sales by Region (2027-2032)
  5. 6.3 Global Bi Yuan Pills Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bi Yuan Pills Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bi Yuan Pills Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bi Yuan Pills Sales Value by Region (2027-2032)
  9. 6.5 Global Bi Yuan Pills Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bi Yuan Pills Sales Value (2021-2032)
  12. 6.6.2 North America Bi Yuan Pills Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bi Yuan Pills Sales Value (2021-2032)
  15. 6.7.2 Europe Bi Yuan Pills Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bi Yuan Pills Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bi Yuan Pills Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bi Yuan Pills Sales Value (2021-2032)
  21. 6.9.2 South America Bi Yuan Pills Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bi Yuan Pills Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bi Yuan Pills Sales Value Share by Country, 2025 VS 2032
7 Bi Yuan Pills Country-level Sales and Value Analysis
  1. 7.1 Global Bi Yuan Pills Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bi Yuan Pills Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bi Yuan Pills Sales by Country (2021-2032)
  4. 7.3.1 Global Bi Yuan Pills Sales by Country (2021-2026)
  5. 7.3.2 Global Bi Yuan Pills Sales by Country (2027-2032)
  6. 7.4 Global Bi Yuan Pills Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bi Yuan Pills Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bi Yuan Pills Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bi Yuan Pills Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bi Yuan Pills Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bi Yuan Pills Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhongjing Wanxi Pharmaceutical Co., Ltd.
  2. 8.1.1 Zhongjing Wanxi Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Zhongjing Wanxi Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Zhongjing Wanxi Pharmaceutical Co., Ltd. Bi Yuan Pills Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhongjing Wanxi Pharmaceutical Co., Ltd. Bi Yuan Pills Product Portfolio
  6. 8.1.5 Zhongjing Wanxi Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Wuhan Taifu Pharmaceutical Co., Ltd.
  8. 8.2.1 Wuhan Taifu Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Wuhan Taifu Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Wuhan Taifu Pharmaceutical Co., Ltd. Bi Yuan Pills Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Wuhan Taifu Pharmaceutical Co., Ltd. Bi Yuan Pills Product Portfolio
  12. 8.2.5 Wuhan Taifu Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Li Shizhen Pharmaceutical Group Co., Ltd.
  14. 8.3.1 Li Shizhen Pharmaceutical Group Co., Ltd. Company Information
  15. 8.3.2 Li Shizhen Pharmaceutical Group Co., Ltd. Business Overview
  16. 8.3.3 Li Shizhen Pharmaceutical Group Co., Ltd. Bi Yuan Pills Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Li Shizhen Pharmaceutical Group Co., Ltd. Bi Yuan Pills Product Portfolio
  18. 8.3.5 Li Shizhen Pharmaceutical Group Co., Ltd. Recent Developments
  19. 8.4 Hubei Minkang Pharmaceutical Co., Ltd.
  20. 8.4.1 Hubei Minkang Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Hubei Minkang Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Hubei Minkang Pharmaceutical Co., Ltd. Bi Yuan Pills Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hubei Minkang Pharmaceutical Co., Ltd. Bi Yuan Pills Product Portfolio
  24. 8.4.5 Hubei Minkang Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd.
  26. 8.5.1 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Bi Yuan Pills Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Bi Yuan Pills Product Portfolio
  30. 8.5.5 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bi Yuan Pills Value Chain Analysis
  2. 9.1.1 Bi Yuan Pills Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bi Yuan Pills Sales Mode & Process
  6. 9.2 Bi Yuan Pills Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bi Yuan Pills Distributors
  9. 9.2.3 Bi Yuan Pills Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research